Skip to main content

Table 6 Association between liver fibrosis status (continuous measure) and a) CD8+ T-cell b) CD4+ T-cell subsets reflecting immunosenesence among art-naïve PLWHA with recent heavy alcohol use

From: Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption - an observational cross-sectional study

a)

CD8+ CD28- CD57+ (as % of CD8+)

Adjusted Mean Difference (95% CI)

P-value

Log(FIB-4) ≤ 1

6.2 (− 0.70, 13.18)

0.08

Log(FIB-4) > 1

−5.54 (− 13.6, 2.47)

0.17

Age/years

−0.06 (− 0.58, 0.45)

0.80

Female sex

−0.83 (−7.68, 6.01)

0.81

Log10(HIV-1 RNA)

−0.45 (− 3.15, 2.25)

0.74

Heavy drinking

1.24 (−8.99, 11.47)

0.81

Injection drug use

3.54 (−3.12, 10.20)

0.30

Current smoking

−0.55 (−9.53, 8.43)

0.90

Years since HIV diagnosis

−0.08 (− 0.68, 0.52)

0.79

Hepatitis C

4.32 (−5.33, 13.97)

0.38

Hepatitis B

−3.69 (− 10.34, 2.97)

0.27

Shingles

0.32 (−6.82, 7.46)

0.93

Tuberculosis

3.11 (−5.82, 12.04)

0.49

b)

CD4+ CD28- CD57+ (as% of CD4+)

Adjusted Mean Difference (95% CI)

P-value

Log(FIB-4)

0.99 (0.64, 1.54)

0.97

Age/years

1.05 (0.99, 1.10)

0.09

Female sex

0.83 (0.41, 1.71)

0.62

Log10(HIV-1 RNA)

0.90 (0.68, 1.20)

0.48

Heavy drinking

1.07 (0.37, 3.14)

0.90

Injection drug use

1.09 (0.54, 2.19)

0.81

Current smoking

0.89 (0.35, 2.27)

0.80

Years since HIV diagnosis

0.99 (0.93, 1.05)

0.68

Hepatitis C

0.34 (0.13, 0.93)

0.04

Hepatitis B

0.62 (0.31, 1.24)

0.18

Shingles

1.34 (0.63, 2.81)

0.44

Tuberculosis

0.92 (0.36, 2.36)

0.87